益方生物股价跌5.02%，国联基金旗下1只基金重仓，持有9.61万股浮亏损失12.97万元

Group 1 - Yifang Biotechnology experienced a decline of 5.02% on November 21, with a stock price of 25.52 yuan per share and a trading volume of 172 million yuan, resulting in a total market capitalization of 14.759 billion yuan [1] - The company, established on January 11, 2013, and listed on July 25, 2022, is located in the Shanghai Free Trade Zone and focuses on the research, production, and sales of innovative drugs, with 100% of its revenue derived from technology licensing and cooperation [1] Group 2 - Guolian Fund has one fund heavily invested in Yifang Biotechnology, specifically the Guolian Medical Consumption Mixed A (015032), which reduced its holdings by 56,100 shares in the third quarter, now holding 96,100 shares, representing 5.66% of the fund's net value [2] - The fund has a total scale of 29.6304 million yuan and has achieved a year-to-date return of 42.87%, ranking 1202 out of 8136 in its category, with a one-year return of 31.69%, ranking 1858 out of 8056 [2]